Editorial: inaccuracies in attribution of symptoms due to gluten-not just in those with self-reported noncoeliac gluten sensitivity. Authors' reply
- PMID: 31943270
- DOI: 10.1111/apt.15629
Editorial: inaccuracies in attribution of symptoms due to gluten-not just in those with self-reported noncoeliac gluten sensitivity. Authors' reply
Comment on
-
Masked bolus gluten challenge low in FODMAPs implicates nausea and vomiting as key symptoms associated with immune activation in treated coeliac disease.Aliment Pharmacol Ther. 2020 Jan;51(2):244-252. doi: 10.1111/apt.15551. Epub 2019 Nov 26. Aliment Pharmacol Ther. 2020. PMID: 31769533 Clinical Trial.
-
Editorial: inaccuracies in attribution of symptoms due to gluten-not just in those with self-reported noncoeliac gluten sensitivity.Aliment Pharmacol Ther. 2020 Feb;51(3):402-403. doi: 10.1111/apt.15620. Aliment Pharmacol Ther. 2020. PMID: 31943272 No abstract available.
References
REFERENCES
-
- Gibson PR. Editorial: inaccuracies in attribution of symptoms due to gluten - not just in those with self-reported non-coeliac gluten sensitvity. Aliment Pharmacol Ther. 2020; in press.
-
- Halmos EP, Power VA, Shepherd SJ, Gibson PR, Muir JG. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology. 2014;146:67-75; e5.
-
- Goel G, Tye-Din JA, Qiao S-W, et al. Cytokine release and gastrointestinal symptoms after gluten challenge in celiac disease. Sci Adv. 2019;5:eaaw7756.
-
- Tye-Din JA, Skodje GI, Sarna VK, et al. Cytokine release after gluten ingestion differentiates coeliac disease from self-reported gluten sensitivity. United Eur Gastroenterol J. 2019. https://doi.org/10.1177/2050640619874173
-
- Goel G, King T, Daveson AJ, et al. Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies. Lancet Gastroenterol Hepatol. 2017;2:479-493.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical